PeptideStack
5.2kquestions
20kanswers
220users

Does lipase tell me anything about hepatic fat on cagrilintide?

Asked 3 Mar 2025Modified 13 months agoViewed 33k times
29

The specifics, since they change the answer: lipase · cagrilintide.

The empirical answer seems settled. The explanation does not.

If the honest answer is that nobody knows, I would rather hear that than a plausible story.

What is the causal chain, and where does it stop being established?

liver-enzymes
liver-enzymes

ALT, AST, GGT and ALP: what they do and do not indicate about hepatic fat, why enzymes are a poor surrogate for histology, and where non-invasive…

91 questions
mash
mash

Metabolic dysfunction-associated steatohepatitis: histological endpoints, resolution without worsening fibrosis, fibrosis improvement by stage,…

56 questions
bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
ZA
askedzeynep_arslan16k263 Mar 2025
2Same laboratory as last time? Between-laboratory differences are larger than most of the changes people chase. – assay_blank 4 months ago
3Can you say how far out of range rather than that it was flagged? The flag is a threshold, not a finding. – sian_llewellyn 5 months ago
add a comment

3 Answers

Accepted answer first, then by votes
54

Accepted answer

Start with the pattern. A hepatocellular pattern with alanine aminotransferase above aspartate aminotransferase points one way; a cholestatic pattern with alkaline phosphatase and gamma-glutamyl transferase points another.

Reference upper limits around forty units per litre for ALT are conventional rather than physiological; several groups have argued for limits closer to thirty for men and twenty-five for women.

Headline results, principal programmes

TrialAgentnDurationPrimary result
STEP 1Semaglutide 2.4 mg1,96168 wk−14.9 % vs −2.4 % weight
STEP 2Semaglutide 2.4 mg, T2DM1,21068 wk−9.6 % vs −3.4 % weight
SURMOUNT-1Tirzepatide 5/10/15 mg2,53972 wk−15 / −19 / −21 % weight
SURMOUNT-4Tirzepatide, withdrawal67088 wkContinued loss vs substantial regain
SELECTSemaglutide 2.4 mg17,604~40 moMACE HR 0.80 (0.72–0.90)
FLOWSemaglutide 1.0 mg, CKD3,533~3.4 yrRenal composite reduced; stopped early
SURMOUNT-OSATirzepatide, OSA46952 wkAHI reduced with and without PAP

Creatine kinase, alkaline phosphatase and bilirubin together tell you which compartment the abnormality is in, and ordering the transaminases alone throws that information away.

Population data show a substantial fraction of adults with mild transaminase elevation attributable to hepatic steatosis, which sets the base rate against which any new finding should be read.

Read the pattern before the magnitude, and the magnitude in multiples of the upper limit.

edited 16 Jun 2025 by mateo_iglesias — removed a claim I could not source

shareimprove this answerflag
MI
answered · acceptedmateo_iglesias12k1627 May 2025
2Minor: haemolysis inflates potassium enough to cause a fright over what is a handling artefact. – loss_on_drying 28 days ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
49

The short version: enzymes in this class usually fall as weight falls, and a rise is a reason to look for a cause rather than to assume a drug effect.

Hy's law describes the combination that matters: transaminases above three times the upper limit together with bilirubin above twice the upper limit and no cholestatic explanation. That combination is a signal; isolated mild transaminase elevation is not.

More usefully, an isolated result three weeks after starting anything is difficult to interpret. A baseline taken before starting makes the same result trivially interpretable, which is the argument for baselines.

Nothing here is medical advice. An abnormal result needs somebody who can take a history and examine you.

Transaminases plus bilirubin plus alkaline phosphatase, or you have not measured enough to conclude anything.

shareimprove this answerflag
DZ
answeredDr_Marek_Zielinski27k2716 May 2025
-3

Answering this needs the magnitude in multiples of the upper reference limit, because the thresholds that matter clinically are defined that way and not in absolute units.

Gamma-glutamyl transferase is sensitive and unspecific: it rises with alcohol, with several medications and with fatty liver, and an isolated elevation rarely changes anything on its own.

Concretely, alanine aminotransferase is relatively liver-specific; aspartate aminotransferase is also present in muscle, heart and red cells. A raised AST with a normal ALT after heavy resistance training is usually muscle, and creatine kinase settles the question.

Laboratory-specific reference intervals for transaminases vary enough that cross-laboratory comparison of borderline values is unreliable.

Research-use material of unknown content is an unquantifiable variable in any such attribution.

Isolated mild elevation is common and usually improves with weight loss.

shareimprove this answerflag
DC
answeredDr_Idris_Coulibaly33k1377 Jun 2025
3Same laboratory every time is advice I ignored for a year, and the series was useless because of it. – Dr_Ilse_Vandenberg 5 months ago
4Small correction: eGFR is an estimate derived from creatinine, not a measurement, and the equation used matters. – esther_vandeVelde 7 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.